← Open Payments lookup

JESSICA SWANSON: Open Payments

NPI 1467144741 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,345 in 200 payments from 17 companies in 2025. Trend: 2023 $963 · 2024 $2,303 · 2025 $4,345

Food & beverage: $4,233Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.23$753
Teva Pharmaceuticals USA, Inc.29$629
Alkermes, Inc.22$547
Otsuka America Pharmaceutical, Inc.22$469
E.R. Squibb & Sons, L.L.C.22$465
ABBVIE INC.25$324
Vanda Pharmaceuticals Inc.11$317
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$210
Janssen Pharmaceuticals, Inc7$143
Axsome Therapeutics, Inc.7$132

Products named: INGREZZA, COBENFY, ARISTADA, REXULTI, VRAYLAR, FANAPT, AUSTEDO XR, UZEDY.

Industry payments across FL — which companies pay providers there.